Relapsing polychondritis (RP), which is a multisystem, inflammatory, autoimmune disease affecting the cartilage, is relatively rare. RP is characterized by swelling of the auricles, audiovestibular disorders, and airway chondritis. Symptoms commonly appear in the ears, neck, and throat. Here in, we describe the case of a patient with RP who developed complete, bilateral hearing loss over the course of one to two months.
A 69-year-old, woman presented with a history of left auricular swelling, vertigo, and bilateral hearing impairment. She had previously been diagnosed as having incomplete Ramsay Hunt syndrome and treated with steroids, but her hearing had failed to improve. Over the course of time, the bilateral hearing impairment progressed to complete deafness. She was referred to our hospital for further management of the deafness and subglottic swelling and was admitted for treatment.
An auricular cartilage biopsy revealed no lymphocytic infiltration, but showed cartilage degeneration. Based on these findings, the patient was diagnosed as having auricular chondritis.
RP was later diagnosed based on the presence of bilateral auricular swelling, airway chondritis, episcleritis, and audiovestibular disorders, which fulfilled the diagnostic criteria for the disease. Pulse methylprednisolone therapy improved the subglottic swelling, auricular swelling, and episcleritis. Although the patient also received intravenous cyclophosphamide therapy (IVCY), the bilateral hearing loss failed to improve.
Inner ear disorders in RP are often resistant to steroid therapy and have a poor, long-term prognosis. The patient received steroid treatment from an early stage, but her hearing failed to improve. Based on a previous study demonstrating the efficacy of cochlear implants in cases of RP-related hearing loss, cochlear implants were recommended to the patient, but she declined the surgery.
Histopathological diagnosis of RP is often made during steroid and/or immunosuppressant therapy administration, as in this case, or afterwards, so that the typical features of the disease may not be evident. Therefore, when making a histopathological diagnosis, it is necessary to consider the possibility that the findings may have been affected by previous treatments.
抄録全体を表示